Source: MedRobot; Editor: Jacky
Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.On November 1, 2023, Corin Group, an innovative orthopedic medical device company, announced that its Apollo™ robotic-assisted surgery platform and ApolloKnee™ software application have received FDA 510(k) clearance.
# Apollo™ Robotic-Assisted Surgery Platform Receives FDA Approval
Corin Group Continues to Focus on Improving Patient Satisfaction and Outcomes in Total Joint Arthroplasty. This Approval Marks an Important Industry Milestone for the Company.Dr. Jim Pierrepont, Global Franchise Director of Corin Group, stated that the Apollo™ Robotic Surgery Platform combines target planning, precision operation, and continuous learning to support total joint replacement. The Apollo™ platform offers advantages in personalized alignment of the knee during surgery.Corin Group's proprietary BalanceBot™ technology is the world's first and only system capable of providing personalized dynamic balance for each patient.
▲Image SourceOfficial CompanyNetwork (hereinafter the same)
Corin's experience in the field of robot-assisted total knee arthroplasty (TKA) began with its OMNIBotics® technology, which has gained worldwide recognition for its surgical precision, efficiency, and critical role in defining dynamic joint balance. The Apollo™ platform, incorporating BalanceBot™ technology, is built on a decade of clinical success, focusing on improving patient outcomes while providing surgeons with a more intuitive surgical experience.In the coming years, the Apollo™ platform technology will expand its capabilities to other clinical applications in joint replacement surgery. This approval marks a new chapter in Corin's innovation journey. Guided by the Apollo™ platform, the company will enhance overall patient satisfaction in joint replacement through targeted planning, precise implantation, and data-driven continuous learning.
# About Apollo™ Surgical Robot
ApolloKnee™ combines target planning, precise operation, and continuous learning to optimize total joint replacement, aiming to enhance the surgical experience for patients.Corin Group is a UK-based medical device company founded in 1985. The company focuses on the development and production of medical devices for orthopedic surgeries, with main products including artificial joints, orthopedic surgical instruments, and orthopedic surgical navigation systems.Corin Group's products are mainly used in orthopedic surgery fields such as artificial joint replacement surgery, joint repair surgery, and fracture repair surgery. The company's products are widely used in hospitals and clinics worldwide and currently have customers and branches in more than 50 countries. The company is committed to improving the outcomes of orthopedic surgeries and the quality of patient recovery through technological innovation and product development. With a professional research and development team and technical support team, the company continuously launches advanced medical devices and equipment, making significant contributions to the development of the healthcare industry.The company’s vision is to advance orthopedics by providing technology-driven procedural workflows and personalized dynamic balancing techniques for every total joint replacement. Its unique combination of advanced robotics and artificial intelligence, along with clinically proven implants, aims to deliver better treatment outcomes for patients, surgeons, and healthcare providers while maximizing healthcare value.
Well-known Surgical Robotics Companies in China:
